Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cellular Nanomed
Irvine, California, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Cellular Nanomed’s patented magnetoelectric nano-therapy using magnetoelectric nanoparticles (MENPs) has shown strong preclinical efficacy in murine pancreatic ductal adenocarcinoma xenograft models, where a single MENP treatment combined with an external magnetic field produced approximately threefold median tumor volume reduction, complete responses in about one-third of mice, and significantly prolonged survival with no evident organ toxicity; clinical trials have not yet started and the company’s work remains at the pre-clinical/animal-study stage.[3]
- Therapeutic areas
- OncologyNeurology
- Modalities
- NanoparticleDeviceNanotechnology-based therapy
- Industry
- Biotech
02
Partnerships
Defense Advanced Research Projects Agency (DARPA) – Next-Generation Non-Surgical Neurotechnology (N3) for Brain-Computer Interface research contract[1][6][8]NCI Moffitt Cancer Center – preclinical pancreatic ductal adenocarcinoma xenograft studies[3]University of Miami – research collaboration on magnetoelectric nanoparticles and brain activation/BCI[3][8]Indiana University School of Medicine – MENP-related collaborations[3]Carnegie Mellon University – MENP and neurotechnology collaborations[1][3]Battelle Memorial Institute – DARPA N3 collaboration[1]IUPUI (Indiana University–Purdue University Indianapolis) – DARPA N3 collaboration[1]
Beyond the preview
Go deeper on Cellular Nanomed.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cellular Nanomed.